Support Alert

Class 4 medicines defect information: Co-Amoxiclav 1000mg/200mg Powder for Solution

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 4 drug alert for specified batches of Co-Amoxiclav 1000mg/200mg Powder for Solution. An investigation has identified that all the affected batches were filled on an alternative filling line by their contract manufacture and an issue during filling has resulted in up to 5% of vials from these batches being discoloured.

Further details of the affected batch and action to take are available on the MHRA website.